Inmarsat president: Governments must solve space junk to reach net zero October 27, 2022 British satellite giant Inmarsat has a message to governments worldwide: “Make sure space is still available to all” or risk losing out on significant CO2 reduction benefits. With the likes of Elon Musk ramping up activity in space, it has been warned that an average of one tonne of ‘stuff’ could be launched into orbit [...]
Spotify calls out ‘kafkaesque’ App Store regulations in its audiobook push October 26, 2022 The boss of Spotify has criticised Apple for stifling its big break into audiobooks, calling its rules around customer access “kafkaesque”. The music streaming firm first announced that it would be pushing into audiobooks back in September, offering a potential rival to Amazon’s Kindle services in the US market. However, Spotify CEO Daniel Ek told [...]
Investors bet on AstraZeneca’s experimental breast cancer drug following positive trial October 26, 2022 Shares rose in AstraZeneca today on the back of progress made with its breast cancer treatment, which combines its older Faslodex drug with a new experimental offering. Breast cancer is the most common cancer in the world, with around 2.3 million patients diagnosed with the disease in 2020. It follows a disappointing result in a [...]
Google and Microsoft drag tech stocks both sides of the Atlantic October 26, 2022 Disappointing results from both Google owner Alphabet and Microsoft have dragged down tech shares both sides of the Atlantic. Nasdaq was down two per cent at the opening bell, whilst European tech stocks fell 1.8 per cent to lead sectoral losses. It comes after Alphabet said third-quarter revenue grew six per cent to $69.1bn, raising [...]
Data protection watchdog warns against ‘immature’ biometric technology October 26, 2022 The UK’s data protection watchdog has warned against businesses using “immature” technology to measure biometrics, saying the risks currently outweigh the benefits. Emotional analysis technologies process data such as gaze tracking, facial movements, heartbeats, facial expressions and skin moisture. Financial services firms often use this technology in their facial recognition practices to verify identities through [...]
Peloton lures CEO back from retirement with £145m package despite tumbling market value October 26, 2022 Peloton lured chief exec Barry McCarthy out of retirement with a handsome package worth $168m (£145m), making him one of the highest-paid bosses in the US. McCarthy, who previously served as chief of finance at both Spotify and Netflix, replaced Peloton co-founder John Foley as CEO of the fitness company back in February. McCarthy is often credited [...]
Investors eye MGC Pharma’s Long Covid drug following positive trial October 26, 2022 Medicinal cannabis company MGC Pharmaceutical caught the eyes of investors yesterday, following positive results from a clinical study of its Long Covid drug. The London-listed bio-pharma firm tested its drug Artemic Support on 60 Covid-19 vaccinated patients suffering from Long Covid. Patients who were administered the drug twice a day for six weeks showed “significant [...]
Elon Musk’s $44bn Twitter takeover to close on Friday October 25, 2022 Elon Musk’s contested $44bn bid for Twitter could reportedly close as soon as Friday. Musk, currently the world’s richest man, is reported to have promised bankers on a video call that the deal would be wrapped up before the end of the week, Bloomberg reported, citing people familiar with the matter. Equity investors, including Sequoia [...]
AstraZeneca asthma drug misses key marker in late-stage trial October 25, 2022 AstraZeneca’s asthma drug failed to significantly improve difficulties swallowing in a late-stage trial, the pharmaceutical giant announced today. The drug, called Fasenra, met just one of two main goals of a stage III study assessing the treatment’s benefits in a chronic allergic condition that causes difficulty in swallowing. The condition, eosinophilic esophagitis, is characterised by [...]
DeepVerge overhauls leadership team as it hunts for emergency cash October 25, 2022 Listed life sciences firm Deepverge announced it would completely refresh its leadership team today as it scrambles to raise emergency cash.
